Samples #13889, #13891, #13895, and a sample from July 2022 (#13614) contain the same unidentified substance. It appears to be some sort of impurity or analog of fentanyl. [now Tentatively Identified, see below]
Feb 14 2024: The tentative identification of the unspecified fentanyl synthesis byproduct in this sample is 1-(4-(phenethyl(phenyl)amino)piperidin-1-yl)propan-1-one. (Thank you, Y.)
Sep 21 2022: The previously unidentified substance in this sample is likely an inactive fentanyl synthesis byproduct.
Send in a sample for testing
DrugsData tests all psychoactive drugs including ecstasy tablets, powders, research chemicals, novel pschoactive substances, and other drugs through our licensed laboratory. Ecstasy/Molly tablets cost $100. Recreational drug powder/crystal/blotter costs $100. Pharmaceuticals, supplements and all others cost $150 per analysis.
Should the public have access to independent analysis of the products they consume?
The vast majority of analyses of over-the-counter, prescription, and recreational drugs are performed in secret with no independent oversite or review. No other historical record, free from politically-controlled agencies, is currently available in North America nor most other parts of the world.
DrugsData, a project of Erowid Center, needs the support of professionals, students, parents, individuals with means, and small foundations for a total yearly budget of around $120,000 USD. Erowid Center's general budget and the co-pays we require fund most of this cost.
Sep 21 2022: The previously unidentified substance in this sample is likely an inactive fentanyl synthesis byproduct.